Scholars@Duke publication: Is there a duty to inform patients of phase I trials?

Is there a duty to inform patients of phase I trials?

Publication , Journal Article

Bruce, CR; Flamm, AL; Leblanc, TW; Rosoff, PM

Published in: Virtual Mentor

March 1, 2009

Published version (DOI) Link to item

Duke Scholars

Author Thomas William LeBlanc Medicine, Hematologic Malignancies and Cellular Therapy

Author Philip Martin Rosoff Pediatrics, Hematology-Oncology

Published In

Virtual Mentor

DOI

10.1001/virtualmentor.2009.11.3.ccas2-0903

ISSN

1937-7010

Publication Date

March 1, 2009

Volume

Issue

Start / End Page

207 / 214

Location

United States

Citation

APA

Chicago

ICMJE

MLA

NLM

Bruce, C. R., Flamm, A. L., Leblanc, T. W., & Rosoff, P. M. (2009). Is there a duty to inform patients of phase I trials? Virtual Mentor, 11(3), 207–214. https://doi.org/10.1001/virtualmentor.2009.11.3.ccas2-0903

Bruce, Courtenay R., Anne Lederman Flamm, Thomas W. Leblanc, and Philip M. Rosoff. “Is there a duty to inform patients of phase I trials?” Virtual Mentor 11, no. 3 (March 1, 2009): 207–14. https://doi.org/10.1001/virtualmentor.2009.11.3.ccas2-0903.

Bruce CR, Flamm AL, Leblanc TW, Rosoff PM. Is there a duty to inform patients of phase I trials? Virtual Mentor. 2009 Mar 1;11(3):207–14.

Bruce, Courtenay R., et al. “Is there a duty to inform patients of phase I trials?” Virtual Mentor, vol. 11, no. 3, Mar. 2009, pp. 207–14. Pubmed, doi:10.1001/virtualmentor.2009.11.3.ccas2-0903.

Bruce CR, Flamm AL, Leblanc TW, Rosoff PM. Is there a duty to inform patients of phase I trials? Virtual Mentor. 2009 Mar 1;11(3):207–214.

Published In

Virtual Mentor

DOI

10.1001/virtualmentor.2009.11.3.ccas2-0903

ISSN

1937-7010

Publication Date

March 1, 2009

Volume

Issue

Start / End Page

207 / 214

Location

United States